使用消耗的酒酵母来封装和提高 Sonochemically 纳米结构的黄素的生物可用性
Irina Kalinina1, Rinat Fatkullin1, Natalya Naumenko1
1Department of Food and Biotechnology, South Ural State University (National Research University), 76 Lenin Avenue, Chelyabinsk 454080, Russia.
International journal of food science
|November 25, 2024
概括
消耗的酒酵母细胞有效地封装了抗氧化剂黄素. 这种新的方法提高了黄素的生物可用性,为酵母废物利用提供了可持续的解决方案.
科学领域:
- 生物技术是生物技术.
- 食品科学 食品科学 食品科学
- 可持续化学 可持续化学
背景情况:
- 消耗的酒酵母 (Saccharomyces cerevisiae) 是一个大量的有机废物流,存在处理方面的挑战.
- 黄素是一种强大的植物抗氧化剂,具有较差的生物可用性.
- 开发可持续的黄素输送方法对于其治疗应用至关重要.
研究的目的:
- 为了研究使用废弃的酵母细胞作为黄素的纳米结构输送系统.
- 为了评估黄素在酵母细胞中的封装效率.
- 评估酵母细胞封装对黄素生物可用性的影响,使用体外消化模型.
主要方法:
- 纳米结构的黄素封装在已使用的Saccharomyces cerevisiae细胞中.
- 使用激光动态光散射,显微镜 (反向和发光) 和FTIR分析对封装过程的描述.
- 封装效率的评估和体外胃消化模型.
主要成果:
- 消耗的酵母细胞表现出作为黄素输送系统的能力.
- 对于预纳米结构的黄素,实现了 47.7% 的封装效率.
- 在体外胃消化模型中证明了79.5%的显著黄素保留率.
结论:
- 消耗的酒酵母细胞是封装黄素的可行和可持续的矩阵.
- 酵母细胞封装显著改善了黄素的潜在生物可用性.
- 这种方法为有机废物提供了一个有前途的价值化策略,同时提高了抗氧化剂的输送.
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
361
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
361
Bioavailability Enhancement: Drug Solubility Enhancement
504
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
504
Bioavailability Enhancement: Drug Permeability Enhancement
358
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
358
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
Bioreactor Controls-III
70
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
70


